A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2

Aaron W. James, Gregory LaChaud, Jia Shen, Greg Asatrian, Vi Nguyen, Xinli Zhang, Kang Ting, Chia Soo

Research output: Contribution to journalReview article

Abstract

Bone morphogenetic protein-2 (BMP-2) is currently the only Food and Drug Administration (FDA)-approved osteoinductive growth factor used as a bone graft substitute. However, with increasing clinical use of BMP-2, a growing and well-documented side effect profile has emerged. This includes postoperative inflammation and associated adverse effects, ectopic bone formation, osteoclast-mediated bone resorption, and inappropriate adipogenesis. Several large-scale studies have confirmed the relative frequency of adverse events associated with the clinical use of BMP-2, including life-threatening cervical spine swelling. In fact, the FDA has issued a warning of the potential life-threatening complications of BMP-2. This review summarizes the known adverse effects of BMP-2, including controversial areas such as tumorigenesis. Next, select animal models that replicate BMP-2's adverse clinical effects are discussed. Finally, potential molecules to mitigate the adverse effects of BMP-2 are reviewed. In summary, BMP-2 is a potent osteoinductive cytokine that has indeed revolutionized the bone graft substitute market; however, it simultaneously has accrued a worrisome side effect profile. Better understanding of these adverse effects among both translational scientists and clinicians will help determine the most appropriate and safe use of BMP-2 in the clinical setting.

Original languageEnglish (US)
Pages (from-to)284-297
Number of pages14
JournalTissue Engineering - Part B: Reviews
Volume22
Issue number4
DOIs
StatePublished - Aug 1 2016

    Fingerprint

ASJC Scopus subject areas

  • Bioengineering
  • Biomaterials
  • Biochemistry
  • Biomedical Engineering

Cite this

James, A. W., LaChaud, G., Shen, J., Asatrian, G., Nguyen, V., Zhang, X., Ting, K., & Soo, C. (2016). A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2. Tissue Engineering - Part B: Reviews, 22(4), 284-297. https://doi.org/10.1089/ten.teb.2015.0357